Apoptosis in liver disease.
Hayashi
N
N
The First Department of Medicine, Osaka University School of Medicine, Yamadaoka, Suita.
D000818:Animals; D017209:Apoptosis / Q000276:immunology / Q000502:physiology; D006528:Carcinoma, Hepatocellular / Q000473:pathology; D004815:Epidermal Growth Factor / Q000502:physiology; D066257:Heparin-binding EGF-like Growth Factor; D006526:Hepatitis C / Q000276:immunology / Q000473:pathology; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins; D008107:Liver Diseases / Q000276:immunology / Q000473:pathology*; D051379:Mice; D015398:Signal Transduction; D019014:fas Receptor / Q000502:physiology
C587883:HBEGF protein, human; C587884:Hbegf protein, mouse; D066257:Heparin-binding EGF-like Growth Factor; D036341:Intercellular Signaling Peptides and Proteins; D019014:fas Receptor; D004815:Epidermal Growth Factor